Treatment results of the second-line chemotherapy regimen for patients with low-risk gestational trophoblastic neoplasia treated with 5-day methotrexate and 5-day etoposide

OBJECTIVE: Highly effective chemotherapy for patients with low-risk gestational trophoblastic neoplasia (GTN) is associated with almost a 100% cure rate. However, 20%–30% of patients treated with chemotherapy need to change their regimens due to severe adverse events (SAEs) or drug resistance. We ex...

Descripción completa

Detalles Bibliográficos
Autores principales: Kanno, Toshiyuki, Matsui, Hideo, Akizawa, Yoshika, Usui, Hirokazu, Shozu, Makio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6189429/
https://www.ncbi.nlm.nih.gov/pubmed/30207097
http://dx.doi.org/10.3802/jgo.2018.29.e89

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6189429/
https://www.ncbi.nlm.nih.gov/pubmed/30207097
http://dx.doi.org/10.3802/jgo.2018.29.e89

Ejemplares similares